AKRO - Akero Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.40
DETAILS
HIGH:
$56.00
LOW:
$38.00
MEDIAN:
$54.00
CONSENSUS:
$48.40
DOWNSIDE:
11.44%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2025-12-09 | Heyman Tomas J. | director | D-Return | 26,000 | $23.02 | $599K |
| 2025-12-09 | Heyman Tomas J. | director | D-Return | 15,000 | $8.13 | $122K |
| 2025-12-09 | Xu Yuan | director | D-Return | 9,398 | -- | -- |
| 2025-12-09 | Xu Yuan | director | D-Return | 15,000 | $8.13 | $122K |
| 2025-12-09 | Xu Yuan | director | D-Return | 13,000 | $26.32 | $342K |
| 2025-12-09 | Xu Yuan | director | D-Return | 26,000 | $23.02 | $599K |
| 2025-12-09 | Young Jonathan | officer: Chief Operating Officer | D-Return | 28,584 | $21.10 | $603K |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 374,985 | $19.87 | $7.5M |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 292,179 | $29.23 | $8.5M |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 233,252 | $42.95 | $10.0M |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 87,220 | $21.10 | $1.8M |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 10,000 | $16.00 | $160K |
| 2025-12-09 | Cheng Andrew | director, officer: President and CEO | D-Return | 159,762 | -- | -- |
| 2025-12-09 | Harrison Seth Loring | director | D-Return | 15,000 | $8.13 | $122K |
| 2025-12-09 | Harrison Seth Loring | director | D-Return | 9,398 | -- | -- |
| 2025-12-09 | Graham G. Walmsley | director | D-Return | 15,000 | $50.83 | $762K |
| 2025-12-09 | Graham G. Walmsley | director | D-Return | 9,398 | -- | -- |
| 2025-12-09 | Judy Chou | director | D-Return | 26,000 | $23.02 | $599K |
| 2025-12-09 | Judy Chou | director | D-Return | 15,000 | $50.83 | $762K |
| 2025-12-09 | Rolph Timothy | officer: Chief Scientific Officer | D-Return | 43,810 | -- | -- |
| 2025-12-09 | Rolph Timothy | officer: Chief Scientific Officer | D-Return | 56,579 | $29.23 | $1.7M |
| 2025-12-09 | Iwicki Mark T | director | D-Return | 9,398 | -- | -- |
| 2025-12-09 | Iwicki Mark T | director | D-Return | 11,493 | $6.36 | $73K |
| 2025-12-09 | Iwicki Mark T | director | D-Return | 76,227 | $0.61 | $47K |
| 2025-12-09 | Iwicki Mark T | director | D-Return | 26,000 | $23.02 | $599K |